
Exicure Inc is a biotechnology business based in the US. Exicure shares (XCUR) are listed on the NASDAQ and all prices are listed in US Dollars. Exicure employs 40 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Exicure
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XCUR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Exicure stock price (NASDAQ: XCUR)
Use our graph to track the performance of XCUR stocks over time.Exicure shares at a glance
Latest market close | $2.07 |
---|---|
52-week range | $2.00 - $59.40 |
50-day moving average | $3.74 |
200-day moving average | $11.61 |
Wall St. target price | $93.75 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.62 |
Buy Exicure shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Exicure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Exicure price performance over time
Historical closes compared with the close of $2.07 from 2022-07-01
1 week (2022-06-24) | 1,442.47% |
---|---|
1 month (2022-05-30) | N/A |
3 months (2022-03-30) | N/A |
6 months (2021-12-31) | 924.25% |
1 year (2021-07-02) | 35.29% |
---|---|
2 years (2020-07-02) | -16.53% |
3 years (2019-07-03) | 2.55 |
5 years (2017-06-29) | N/A |
Exicure financials
Revenue TTM | $1.1 million |
---|---|
Gross profit TTM | $-48,839,000 |
Return on assets TTM | -54.81% |
Return on equity TTM | -225.14% |
Profit margin | 0% |
Book value | $0.79 |
Market capitalisation | $8.5 million |
TTM: trailing 12 months
Exicure share dividends
We're not expecting Exicure to pay a dividend over the next 12 months.
Have Exicure's shares ever split?
Exicure's shares were split on a 1:30 basis on 29 June 2022. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Exicure shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Exicure shares which in turn could have impacted Exicure's share price.
Exicure share price volatility
Over the last 12 months, Exicure's shares have ranged in value from as little as $2 up to $59.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Exicure's is 1.2461. This would suggest that Exicure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Exicure overview
Exicure, Inc. , a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S. A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome.
Exicure in the news
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
Frequently asked questions
What percentage of Exicure is owned by insiders or institutions?Currently 33.393% of Exicure shares are held by insiders and 19.84% by institutions. How many people work for Exicure?
Latest data suggests 40 work at Exicure. When does the fiscal year end for Exicure?
Exicure's fiscal year ends in December. Where is Exicure based?
Exicure's address is: 2430 North Halsted Street, Chicago, IL, United States, 60614 What is Exicure's ISIN number?
Exicure's international securities identification number is: US30205M1018 What is Exicure's CUSIP number?
Exicure's Committee on Uniform Securities Identification Procedures number is: 30205M101
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert